Ligand Pharmaceuticals Inc LGND
4 numbers reported differently in a later 10-K
XBRL, 6 10-KsA change is a restatement (the company says the earlier number was wrong) or a recast: after selling a business, adopting an accounting rule or moving amounts between lines, companies redo past years. The later 10-K's notes say which.
First reported, then reported again
Number by number · each number links to its 10-K
Each bar is the change from the number first reported to the number a later 10-K gives, on one scale.
| Number | Period | First reported | Later reported | Change |
|---|---|---|---|---|
| Revenue RevenueFromContractWithCustomerExcludingAssessedTax · link |
Fiscal year ending Dec 31, 2021 | $277.13M 10-K filed Feb 28, 2022 |
$241.54M 10-K filed Feb 28, 2023 |
-12.8% |
| Operating income OperatingIncomeLoss · link |
Fiscal year ending Dec 31, 2021 | $78.89M 10-K filed Feb 28, 2022 |
$103.85M 10-K filed Feb 28, 2023 |
+31.6% |
| Revenue RevenueFromContractWithCustomerExcludingAssessedTax · link |
Fiscal year ending Dec 31, 2020 | $186.42M 10-K filed Feb 24, 2021 |
$163.56M 10-K filed Feb 28, 2023 |
-12.3% |
| Operating income OperatingIncomeLoss · link |
Fiscal year ending Dec 31, 2020 | $25.84M 10-K filed Feb 24, 2021 |
$37.50M 10-K filed Feb 28, 2023 |
+45.1% |
From SEC's XBRL company facts (6 10-K filings). Checked: revenue, operating income, net income, cash from operations, total assets, shareholders' equity, receivables and inventory. Per-share numbers are left out because stock splits change them.
Sources
SEC's XBRL company facts: each 10-K's number for a year, against the number a later 10-K gives for the same year and line.
Also
Accounting checks: the checks run on the latest 10-K.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/LGND/export.csv") into a cell.